KeyMed Biosciences Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - KeyMed Biosciences Inc

Watchlist Manager

Watchlist

Price: 73.55 HKD -3.73% Market Closed

Market Cap: HK$22B

K	KeyMed Biosciences Inc HKEX:2162	CN
	Kasumigaseki Capital Co Ltd TSE:3498	JP
M	MTU Aero Engines AG OTC:MTUAY	DE
	Mitsui Chemicals Inc OTC:MITUY	JP
N	Naspers Ltd XMUN:NNWN	ZA
B	Bilfinger SE XHAM:GBF	DE
N	Nippon Yusen KK F:NYKA	JP
T	Terreno Realty Corp F:T37	US
	Netscout Systems Inc NASDAQ:NTCT	US
	Swiss Re AG SIX:SREN	CH
	Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	CN
	Candel Therapeutics Inc NASDAQ:CADL	US
	Charter Communications Inc NASDAQ:CHTR	US
A	AltaGas Ltd F:AQ3	CA
S	Sumitomo Realty & Development Co Ltd OTC:SURDF	JP

Profitability Summary

KeyMed Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

95% > 88%

Negative Operating Margin

-80%

Negative 3Y Average Operating Margin

-269%

Operating Margin is Increasing

-119% > -80%

Negative Net Margin

-73%

Negative 3Y Average Net Margin

-247%

Net Margin is Increasing

-81% > -73%

Negative Free Cash Flow Margin

-146%

Negative 3Y Average Free Cash Flow Margin

-355%

Free Cash Flow Margin is Increasing

-180% > -146%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-45% > -30%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.